{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:50:33Z","timestamp":1791946233364,"version":"4.3.4"},"reference-count":34,"publisher":"Informa UK Limited","issue":"3-4","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/mark\/1.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"],"published-print":{"date-parts":[[2025,4,3]]},"DOI":"10.1080\/21678421.2024.2447919","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T05:44:52Z","timestamp":1735883092000},"page":"290-295","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":53,"title":["Amyotrophic lateral sclerosis estimated prevalence cases from 2022 to 2030, data from the national ALS Registry"],"prefix":"10.1080","volume":"26","author":[{"given":"Paul","family":"Mehta","sequence":"first","affiliation":[{"name":"Office of Innovation and Analytics, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Raymond","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Nair","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon","family":"Han","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Berry","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Punjani","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Larson","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraya","family":"Mohidul","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Kevin","family":"Horton","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"National Institute of Health (NIH). Amyotrophic lateral sclerosis (ALS): NIH | National Institute of Neurological Disorders and Stroke; 2024 [updated July 19 2024]. https:\/\/www.ninds.nih.gov\/health-information\/disorders\/amyotrophic-lateral-sclerosis-als."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052400"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01272-7"},{"key":"e_1_3_3_5_1","first-page":"e30035","article-title":"Riluzole and Edavarone: The hope against amyotrophic lateral sclerosis","volume":"14","author":"Rokade AV","year":"2022","unstructured":"Rokade AV, Yelne P, Giri A. Riluzole and Edavarone: The hope against amyotrophic lateral sclerosis. Cureus 2022;14:e30035.","journal-title":"Cureus"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells13110888"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2024.2336110"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117719"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2021.1910308"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27085"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-017-9740-y"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2021.09.004"},{"key":"e_1_3_3_13_1","unstructured":"Service UPH. ALS registry act 110th congress. Public law. Washington D.C. 2008. p. 110\u2013373."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2024.2358786"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2023.2245858"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2022.2059380"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2021.1949021"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6746a1"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6707a3"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6508a1"},{"key":"e_1_3_3_21_1","first-page":"1","article-title":"Division of T, Human Health Sciences AfTS, et\u00a0al. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011","volume":"63","author":"Mehta P","year":"2014","unstructured":"Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, et\u00a0al. Division of T, Human Health Sciences AfTS, et\u00a0al. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011. MMWR Suppl. 2014;63:1\u201314.","journal-title":"MMWR Suppl"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2021.2023190"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000488891"},{"key":"e_1_3_3_24_1","unstructured":"US Census Bureau. 2023 National Population Projections Datasets: United States Census Bureau; 2023. https:\/\/www.census.gov\/data\/datasets\/2023\/demo\/popproj\/2023-popproj.html"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2014.887119"},{"key":"e_1_3_3_26_1","unstructured":"US Census Bureau. National population by characteristics: 2010-2019: United States Census Bureau; 2022. https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2010s-national-detail.html"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.996"},{"key":"e_1_3_3_28_1","unstructured":"Penn State\u2019s Department of Statistics. 9.1 - Confidence Intervals for a Population Proportion: Penn State | Eberly College of Science; 2024. https:\/\/online.stat.psu.edu\/stat100\/lesson\/9\/9.1"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12408"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30404-6"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00080"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1415-0"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114378"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.2217\/rme.11.6"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2017.1406953"}],"container-title":["Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21678421.2024.2447919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:17:35Z","timestamp":1748963855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21678421.2024.2447919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":34,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2025,4,3]]}},"alternative-id":["10.1080\/21678421.2024.2447919"],"URL":"https:\/\/doi.org\/10.1080\/21678421.2024.2447919","relation":{},"ISSN":["2167-8421","2167-9223"],"issn-type":[{"value":"2167-8421","type":"print"},{"value":"2167-9223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iafd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iafd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}